• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Combination of Electroconvulsive Therapy Alternating With Intravenous Esketamine Can Lead to Rapid Remission of Treatment Resistant Depression.

作者信息

Kavakbasi Erhan, Hassan Ahmed, Baune Bernhard T

出版信息

J ECT. 2021 Jun 1;37(2):e20-e21. doi: 10.1097/YCT.0000000000000733.

DOI:10.1097/YCT.0000000000000733
PMID:33337652
Abstract
摘要

相似文献

1
Combination of Electroconvulsive Therapy Alternating With Intravenous Esketamine Can Lead to Rapid Remission of Treatment Resistant Depression.电休克治疗与静脉注射艾司氯胺酮交替联合使用可导致难治性抑郁症快速缓解。
J ECT. 2021 Jun 1;37(2):e20-e21. doi: 10.1097/YCT.0000000000000733.
2
Robust Antidepressant Effect Following Alternating Intravenous Racemic Ketamine and Electroconvulsive Therapy in Treatment-Resistant Depression: A Case Report.交替静脉注射消旋氯胺酮与电休克治疗难治性抑郁症后的强效抗抑郁作用：一例报告
J ECT. 2017 Sep;33(3):e31-e32. doi: 10.1097/YCT.0000000000000421.
3
Antidepressant effect of prolonged twice-weekly intranasal esketamine treatments after nonresponse to electroconvulsive therapy in a patient with treatment-resistant depression.一名难治性抑郁症患者在对电休克治疗无反应后，每周两次延长鼻内给予艾氯胺酮治疗的抗抑郁作用。
Ann Clin Psychiatry. 2022 Feb;34(1):61-64. doi: 10.12788/acp.0055.
4
Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study.灵活剂量依他佐辛鼻喷雾剂联合新起始口服抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机、双盲、活性对照研究。
Am J Psychiatry. 2019 Jun 1;176(6):428-438. doi: 10.1176/appi.ajp.2019.19020172. Epub 2019 May 21.
5
Esketamine for treatment resistant depression: a trick of smoke and mirrors?用于治疗抵抗性抑郁症的 Esketamine：烟雾与镜子的把戏？
Epidemiol Psychiatr Sci. 2019 Dec 16;29:e79. doi: 10.1017/S2045796019000751.
6
A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.氯胺酮在情感障碍中的应用综述：临床疗效的现有证据、使用限制以及作用机制的临床前证据。
J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10.
7
Is Intravenous Ketamine Better Than Intranasal Esketamine for Treating Treatment-Resistant Depression?静脉注射氯胺酮治疗难治性抑郁症是否优于鼻内使用艾司氯胺酮？
Prim Care Companion CNS Disord. 2024 Feb 13;26(1):23lr03607. doi: 10.4088/PCC.23lr03607.
8
Esketamine (Spravato) for Treatment-Resistant Depression.艾氯胺酮（斯普拉维托）用于治疗抵抗性抑郁症。
Am Fam Physician. 2020 Mar 15;101(6):339-340.
9
Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1).依他佐辛鼻喷剂固定剂量联合新型抗抑郁药治疗难治性抑郁症的疗效和安全性：一项随机、双盲、阳性对照研究（TRANSFORM-1）的结果。
Int J Neuropsychopharmacol. 2019 Oct 1;22(10):616-630. doi: 10.1093/ijnp/pyz039.
10
Beneficial pre-ECT ketamine infusion in a patient with treatment-resistant depression.对一名难治性抑郁症患者进行有益的ECT前氯胺酮输注治疗。
Psychosomatics. 2014 Jul-Aug;55(4):396-399. doi: 10.1016/j.psym.2013.12.002. Epub 2013 Dec 4.

引用本文的文献

1
The treatment of depression - searching for new ideas.抑郁症的治疗——探寻新思路。
Front Pharmacol. 2022 Oct 7;13:988648. doi: 10.3389/fphar.2022.988648. eCollection 2022.
2
Efficacy of Analgesic Propofol/Esketamine and Propofol/Fentanyl for Painless Induced Abortion: A Randomized Clinical Trial.丙泊酚/依托咪酯与丙泊酚/芬太尼用于无痛人流的疗效：一项随机临床试验。
Biomed Res Int. 2022 Jun 9;2022:5095282. doi: 10.1155/2022/5095282. eCollection 2022.
3
The antidepressant effect and safety of non-intranasal esketamine: A systematic review.
非鼻腔内用依他佐辛的抗抑郁作用和安全性：系统评价。
J Psychopharmacol. 2022 May;36(5):531-544. doi: 10.1177/02698811221084055. Epub 2022 May 12.